title: An analysis of how the GAVI alliance and low- and middle-income countries can share costs of new vaccines.
abstract: Immunization is one of the "best buys" in global health. However, for the poorest countries, even modest expenditures may be out of reach. The GAVI Alliance is a public-private partnership created to help the poorest countries introduce new vaccines. Since 2008 GAVI has required that countries cover a share of the cost of vaccines introduced with GAVI support. To determine how much countries can contribute to the cost of vaccines--without displacing spending on other essential programs--we analyzed their fiscal capacity to contribute to the purchase of vaccines over the coming decade. For low-income countries, external financing will be required to purchase vaccines supported by GAVI, so co-financing needs to be modest. Relatively better-off "intermediate" countries could support initially modest but gradually increasing co-financing levels. The countries soon to graduate from GAVI can generally afford to follow a rapid path to self-sufficiency. Co-financing for these countries needs to ramp up so that national budgets fully cover the costs of the new generation of vaccines once GAVI support ends.
authors.affiliation: Results for Development Institute, Washington, DC, USA.
authors.forename: Helen
authors.initials: H
authors.lastname: Saxenian
authors.forename: Santiago
authors.initials: S
authors.lastname: Cornejo
authors.forename: Kira
authors.initials: K
authors.lastname: Thorien
authors.forename: Robert
authors.initials: R
authors.lastname: Hecht
authors.forename: Nina
authors.initials: N
authors.lastname: Schwalbe
mesh_terms: D002202:Capital Financing / Q000458:organization & administration*; D003299:Cooperative Behavior; D003361:Cost Allocation / Q000458:organization & administration*; D003906:Developing Countries; D014612:Vaccines / Q000191:economics*
chemical_list: D014612:Vaccines